In breast cancer, breast cancer 1 (BRCA1) mutations often occur after tumor protein 53 (TP53) mutations (Martins et al., 2012), because an initial BRCA1 mutation leads to a cell cycle arrest, which is not in favor of tumor progression (Ashworth et al., 2011). The gene discussed is TP53; the disease is neoplasm.